Taken together, our results strongly suggest that increased expression of transthyretin triggered by hTFAM in both AD model neurons and mouse brain is protective against Aβ toxicity in these models, thereby ameliorating the AD pathophysiology. The gene discussed is TTR; the disease is Alzheimer disease.